Meprobamate: still approved in France: labelling change. No role for meprobamate, in any indication. Safer options are available.
D001007:Anxiety / Q000188:drug therapy*; D017277:Drug Approval; D004348:Drug Labeling; D004359:Drug Therapy, Combination; D005602:France; D006801:Humans; D008620:Meprobamate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D008620:Meprobamate